Franklin Street Advisors’s Halozyme HALO Stock Holding History

Franklin Street Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-50,000	Closed	-$432K	–	188
2016 Q2	$432K	Hold	50,000	–	–	0.08%	133
2016 Q1	$474K	Buy	50,000 +20,000	+67%	+$188K	0.09%	142
2015 Q4	$520K	Hold	30,000	–	–	0.1%	138
2015 Q3	$403K	Buy	+30,000	New	+$602K	0.08%	152
2013 Q4	–	Sell	-35,400	Closed	-$391K	–	229
2013 Q3	$391K	Sell	35,400 -35,450	-50%	-$295K	0.09%	173
2013 Q2	$563K	Buy	+70,850	New	+$451K	0.14%	160

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Street Advisors's HALO Position: Q3 2016 in Review

Franklin Street Advisors sold out of Halozyme (HALO) in Q3 2016, closing a stake of 50,000 shares — an estimated $432K sold.

Franklin Street Advisors first reported a position in HALO in Q2 2013 and held it in 6 quarters. The position peaked at $563K in Q2 2013. 162 funds tracked by Wall St. Rank hold HALO as of Q3 2016.

Franklin Street Advisors reported no remaining Halozyme position as of Q3 2016 after selling out during the quarter.
Franklin Street Advisors sold 50,000 Halozyme shares in Q3 2016, an estimated $432K.
Franklin Street Advisors first reported a position in Halozyme in Q2 2013 and held it in 6 quarters.
Franklin Street Advisors's Halozyme position peaked at $563K in Q2 2013.
162 funds tracked by Wall St. Rank held Halozyme as of Q3 2016.

Based on Franklin Street Advisors's 13F filing for Q3 2016, filed 5 Oct 2016.